Skip to main content
PhoenixBio Co.,Ltd. logo

PhoenixBio Co.,Ltd. — Investor Relations & Filings

Ticker · 6190 ISIN · JP3803010002 T Professional, scientific and technical activities
Open in API
Filings indexed 63 across all filing types
Latest filing 2020-08-12 Interim / Quarterly Rep…
Country JP Japan
Listing T 6190

About PhoenixBio Co.,Ltd.

https://phoenixbio.co.jp/

PhoenixBio is a contract research organization (CRO) specializing in translational animal models for the pharmaceutical industry. The company's core product is the PXB-mouse®, a proprietary chimeric mouse model featuring a liver that is highly repopulated (over 70%) with functional human hepatocytes. This humanized liver model is utilized globally in preclinical studies to evaluate drug metabolism, pharmacokinetics, and toxicity. In addition to supplying the PXB-mouse® and primary human hepatocytes (PXB-cells®), PhoenixBio provides comprehensive, quality-controlled contract study services to support drug discovery and early development projects.

Recent filings

Filing Released Lang Actions
四半期報告書－第20期第1四半期(令和2年4月1日－令和2年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for PhoenixBio Co., Ltd. covering the first quarter of the 20th fiscal period (April 1, 2020, to June 30, 2020). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements and management analysis. This aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-08-12 Japanese
有価証券報告書－第19期(平成31年4月1日－令和2年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains comprehensive financial data, including consolidated and non-consolidated financial indicators, balance sheets, and management information for the fiscal year ending March 31, 2020. It is a full-length regulatory filing, not an announcement or a summary. FY 2020
2020-06-26 Japanese
四半期報告書－第19期第3四半期(令和1年10月1日－令和1年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for PhoenixBio Co., Ltd., covering the third quarter of the 19th fiscal period (October 1, 2019, to December 31, 2019). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, along with notes to the financial statements. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. 9M 2020
2020-02-14 Japanese
四半期報告書－第19期第2四半期(2019/07/01－2019/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for PhoenixBio Co., Ltd. for the second quarter of the 19th fiscal year (ending September 30, 2019). It contains comprehensive financial statements, including the balance sheet, income statement, cash flow statement, and notes to the financial statements, as required by the Financial Instruments and Exchange Act of Japan. It is a substantive financial report rather than an announcement or certification. H1 2020
2019-11-14 Japanese
四半期報告書－第19期第1四半期(2019/04/01－2019/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for PhoenixBio Co., Ltd. covering the first quarter of the 19th fiscal period (April 1, 2019, to June 30, 2019). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, along with notes to the financial statements. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2019
2019-08-09 Japanese
有価証券報告書－第18期(平成30年4月1日－平成31年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It contains detailed financial statements, management discussion, business history, and corporate information for the fiscal year ending March 31, 2019. The document length and content confirm it is the full annual filing, not an announcement or summary. FY 2019
2019-06-28 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.